UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061614
Receipt number R000070491
Scientific Title Clinical Evaluation and Protocol Optimization of a Newly Implemented Advanced Imaging Application: A Prospective Observational Study
Date of disclosure of the study information 2026/07/10
Last modified on 2026/05/18 12:09:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical Evaluation and Protocol Optimization of a Newly Implemented Advanced Imaging Application: A Prospective Observational Study

Acronym

Clinical Evaluation and Protocol Optimization of a New Imaging Application

Scientific Title

Clinical Evaluation and Protocol Optimization of a Newly Implemented Advanced Imaging Application: A Prospective Observational Study

Scientific Title:Acronym

Prospective Evaluation and Optimization of Imaging Protocols for a Novel Image Generation Application

Region

Japan


Condition

Condition

None (Healthy adult volunteers)

Classification by specialty

Radiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to optimize MRI examination protocols at our institution by quantitatively and qualitatively validating the efficacy of a novel imaging technology using biological images of healthy employee volunteers. Furthermore, this study aims to enhance the quality of operational workflow by systematizing this validation process, disseminate the acquired findings academically, and contribute to the widespread adoption of safe diagnostic imaging technologies.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Overall image quality (visual evaluation using a 5-point scale or similar)

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Full-time or part-time employees (healthy volunteers) belonging to the Central Radiology Department of our hospital.

Individuals aged 20 years or older at the time of informed consent.

Individuals who have provided written informed consent to participate in this study.

Key exclusion criteria

Individuals with implanted medical devices (e.g., pacemakers) that are contraindicated for MRI examinations.

Individuals with ferromagnetic metals in their body (e.g., artificial joints, surgical clips) that may affect image quality or compromise safety.

Individuals who cannot tolerate long-duration imaging inside the MRI scanner due to claustrophobia or other reasons.

Individuals who are pregnant or may be pregnant.

Individuals otherwise judged by the principal investigator or sub-investigators to be unsuitable for participation in this study.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Jun
Middle name
Last name Nakane

Organization

Saitama Medical University Saitama Medical Center

Division name

Radiology Department

Zip code

350-8550

Address

1981 Kamoda, Kawagoe, Saitama 350-8550, Japan

TEL

049-228-3510

Email

jun_n@saitama-med.ac.jp


Public contact

Name of contact person

1st name Jun
Middle name
Last name Nakane

Organization

Saitama Medical University Saitama Medical Center

Division name

Radiology Department

Zip code

350-8550

Address

1981 Kamoda, Kawagoe, Saitama 350-8550, Japan

TEL

049-228-3510

Homepage URL


Email

jun_n@saitama-med.ac.jp


Sponsor or person

Institute

Saitama Medical University Saitama Medical Center

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Saitama Medical University Saitama Medical Center

Address

049-228-3510

Tel

049-228-3510

Email

jun_n@saitama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 07 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 07 Month 01 Day

Date of IRB


Anticipated trial start date

2026 Year 07 Month 01 Day

Last follow-up date

2029 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Pending


Management information

Registered date

2026 Year 05 Month 18 Day

Last modified on

2026 Year 05 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070491